VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
COLL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
COLLCollegium Pharmaceutical, Inc.
$25.93$841M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCOLLQuarterly Financials

Collegium Pharmaceutical, Inc. (COLL) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Collegium Pharmaceutical, Inc. (COLL) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

COLL Income Statement

Quarterly statement

COLL Income Statement

Collegium Pharmaceutical, Inc. (COLL) annual income statement — 13-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue216.34M199.88M193.52M205.45M209.36M188M177.76M181.95M159.3M145.28M144.92M149.75M136.71M135.55M144.77M129.62M127.01M123.55M83.75M27.36M
Revenue Growth %3.33%6.32%8.87%12.92%31.42%29.41%22.66%21.51%16.53%7.18%0.11%15.53%7.63%9.71%72.85%373.72%61.1%48.96%-4.53%-64.13%
Cost of Goods Sold90.92M89.59M76.27M77.07M80.19M79.62M80.43M83.66M62.51M54.47M53.47M55.12M56.4M61.72M67.36M79.83M68.17M71.19M35.26M28.7M
COGS % of Revenue42.03%44.82%39.41%37.51%38.3%42.35%45.25%45.98%39.24%37.49%36.89%36.81%41.25%45.53%46.53%61.59%53.67%57.62%42.09%104.87%
Gross Profit125.42M110.29M117.25M128.38M129.17M108.38M97.32M98.29M96.79M90.81M91.46M94.63M80.31M73.83M77.4M49.79M58.84M52.36M48.5M-1.33M
Gross Margin %57.97%55.18%60.59%62.49%61.7%57.65%54.75%54.02%60.76%62.51%63.11%63.19%58.75%54.47%53.47%38.41%46.33%42.38%57.9%-4.87%
Gross Profit Growth %-2.91%1.76%20.47%30.61%33.45%19.36%6.42%3.87%20.52%23%18.16%90.06%36.49%40.99%59.6%3835.11%27.6%4.23%-12.77%-103.01%
Operating Expenses99.59M106.59M85.28M69.15M65.55M73.28M75.64M60.18M61.95M43.34M41.98M32.94M35.3M38.19M52.77M38.03M38.37M41.25M58.51M32.79M
OpEx % of Revenue46.03%53.33%44.07%33.66%31.31%38.98%42.55%33.07%38.89%29.83%28.97%22%25.82%28.18%36.46%29.34%30.21%33.39%69.86%119.83%
Selling, General & Admin99.59M106.59M067.64M65.55M73.64M76.42M63.09M61.95M43.34M41.98M32.94M35.3M38.19M52.77M38.03M38.37M41.25M54.53M26.6M
SG&A % of Revenue46.03%53.33%-32.92%31.31%39.17%42.99%34.68%38.89%29.83%28.97%22%25.82%28.18%36.46%29.34%30.21%33.39%65.11%97.22%
Research & Development0000000000000000003.98M1.61M
R&D % of Revenue------------------4.76%5.88%
Other Operating Expenses001000K1000K0-358K-786K-1000K000000000001000K
Operating Income25.83M3.7M31.96M59.22M63.62M35.1M21.69M38.11M34.84M47.47M49.47M61.69M45.01M35.63M24.63M11.76M20.47M11.11M-10.02M-34.12M
Operating Margin %11.94%1.85%16.52%28.83%30.39%18.67%12.2%20.95%21.87%32.68%34.14%41.2%32.93%26.29%17.01%9.07%16.11%8.99%-11.96%-124.71%
Operating Income Growth %-59.4%-89.47%47.39%55.4%82.61%-26.05%-56.16%-38.22%-22.6%33.22%100.89%424.69%119.93%220.73%345.9%134.46%44.65%-32.29%-147.26%-327.54%
EBITDA29.85M69.1M87.44M115.62M120.13M91.71M78.25M94.62M76.59M82.94M84.91M97.15M82.12M73.88M62.8M54.86M58.42M49.54M9.62M-16.9M
EBITDA Margin %13.8%34.57%45.18%56.28%57.38%48.78%44.02%52.01%48.08%57.09%58.59%64.88%60.07%54.51%43.38%42.32%45.99%40.1%11.49%-61.78%
EBITDA Growth %-75.15%-24.65%11.74%22.19%56.85%10.58%-7.84%-2.6%-6.74%12.26%35.19%77.09%40.57%49.14%552.66%424.56%86.06%47.31%-74.96%-152.7%
D&A (Non-Cash Add-back)065.41M55.47M56.4M56.51M56.61M56.56M56.51M41.75M35.47M35.43M35.46M37.11M38.25M38.18M43.1M37.95M38.43M19.64M17.22M
EBIT29.85M5.99M34.6M133.83M65.2M37.49M23.91M39.92M33.97M44.68M53.96M65.99M49.55M39.66M3.87M12.78M20.48M11.12M-10.01M-34.12M
Net Interest Income-20.82M-17.23M-12.16M-101.23M-18.65M-18.08M-18.57M-20.84M-15.11M-11.19M-12.85M-14.98M-16.23M-17.84M-18.68M-19.55M-19.04M-17.76M-5.83M-4.75M
Interest Income1.13M2.29M3.71M3.56M3.12M2.38M2.23M1.81M3.28M4.4M4.49M4.3M4.54M4.03M2.75M1.03M11K5K4K3K
Interest Expense21.94M19.52M15.86M104.79M21.77M20.46M20.79M22.65M18.39M15.59M17.34M19.28M20.77M21.86M21.43M20.57M19.05M17.76M5.83M4.76M
Other Income/Expense-17.92M-17.23M-13.22M-30.19M-20.18M-18.08M-18.57M-20.84M-19.26M-18.37M-12.85M-14.98M-16.23M-17.84M-42.18M-19.55M-19.04M-17.76M-5.83M-4.75M
Pretax Income7.91M-13.53M18.74M29.04M43.44M17.02M3.12M17.27M15.58M29.1M36.62M46.71M28.78M17.8M-17.56M-7.79M1.43M-6.65M-15.84M-38.88M
Pretax Margin %3.65%-6.77%9.68%14.13%20.75%9.06%1.76%9.49%9.78%20.03%25.27%31.19%21.05%13.13%-12.13%-6.01%1.13%-5.38%-18.92%-142.08%
Income Tax-13.85M1.52M4.24M12.07M11.93M5.04M705K4.73M6.25M9.49M8.91M14.77M8.15M4.79M-131K-592K975K-1.46M-2.77M-13.84M
Effective Tax Rate %-175.22%-11.23%22.65%41.58%27.46%29.62%22.58%27.41%40.08%32.62%24.33%31.62%28.31%26.91%0.75%7.6%68.09%21.89%17.5%35.61%
Net Income21.76M-15.05M14.5M16.96M31.51M11.98M2.42M12.54M9.34M19.61M27.71M31.94M20.63M13.01M-17.43M-7.2M457K-5.19M-13.07M-25.03M
Net Margin %10.06%-7.53%7.49%8.26%15.05%6.37%1.36%6.89%5.86%13.5%19.12%21.33%15.09%9.6%-12.04%-5.55%0.36%-4.2%-15.6%-91.49%
Net Income Growth %-30.94%-225.6%499.75%35.31%237.51%-38.88%-91.28%-60.75%-54.76%50.73%259.03%543.67%4415.1%350.57%-33.34%71.24%-94.32%-107.13%-183.44%-459.79%
Net Income (Continuing)21.76M-15.05M14.5M16.96M31.51M11.98M2.42M12.54M9.34M19.61M27.71M31.94M20.63M13.01M-17.43M-7.2M457K-5.19M-13.07M-25.03M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.60-0.460.400.460.840.340.070.350.270.520.710.820.530.34-0.51-0.210.01-0.15-0.39-0.73
EPS Growth %-28.57%-235.29%443.48%31.43%211.11%-34.62%-89.63%-57.32%-49.06%52.94%239.22%490.48%3915.15%326.67%-30.77%71.23%-94%-108.38%-195.12%-465%
EPS (Basic)0.69-0.460.450.541.000.380.080.390.330.600.860.990.610.38-0.51-0.210.01-0.15-0.39-0.73
Diluted Shares Outstanding39.11M32.46M40.07M39.7M39.44M39.08M32.84M40.11M40.16M40.38M41.44M41.28M42.06M42.85M34.32M33.58M34.57M34M33.67M34.12M
Basic Shares Outstanding31.73M32.46M32.09M31.71M31.57M31.81M31.79M32.08M32.26M32.43M32.33M32.3M33.74M34.62M34.32M33.58M34.06M34M33.51M34.11M
Dividend Payout Ratio--------------------